Page last updated: 2024-08-21

perflubron and Dermatitis Medicamentosa

perflubron has been researched along with Dermatitis Medicamentosa in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Flaim, KE; Keipert, PE; Leese, PT; Noveck, RJ; Shannon, EJ; Shorr, JS; Woods, CM	1

Trials

1 trial(s) available for perflubron and Dermatitis Medicamentosa

Article	Year
Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers. Anesthesia and analgesia, 2000, Volume: 91, Issue:4 Topics: Adolescent; Adult; Antibody Formation; Complement Activation; Contrast Media; Dose-Response Relationship, Drug; Double-Blind Method; Drug Eruptions; Emulsions; Female; Fluorocarbons; Follow-Up Studies; Humans; Hydrocarbons, Brominated; Hypersensitivity, Delayed; Immunity, Cellular; Immunoglobulins; Injections, Intravenous; Interleukin-1; Interleukin-6; Lymphocyte Activation; Macrophage Activation; Male; Middle Aged; Particle Size; Phagocytes; Placebos; Prospective Studies; Safety; Tumor Necrosis Factor-alpha	2000

Article

Year

Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers.

Anesthesia and analgesia, 2000, Volume: 91, Issue:4

Topics: Adolescent; Adult; Antibody Formation; Complement Activation; Contrast Media; Dose-Response Relationship, Drug; Double-Blind Method; Drug Eruptions; Emulsions; Female; Fluorocarbons; Follow-Up Studies; Humans; Hydrocarbons, Brominated; Hypersensitivity, Delayed; Immunity, Cellular; Immunoglobulins; Injections, Intravenous; Interleukin-1; Interleukin-6; Lymphocyte Activation; Macrophage Activation; Male; Middle Aged; Particle Size; Phagocytes; Placebos; Prospective Studies; Safety; Tumor Necrosis Factor-alpha

2000